Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. GERN
    4. >
  4. Valuation

Valuation

-
stocks logo
GERN
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is GERN Overvalued？

GERN is now in the zone, suggesting that GERN current forward PE ratio of -15.80 is considered compare with the five-year average of -8.08.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

GERN Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
GERN.O
Geron Corp
loss
Average P/E: 17.83
56.29%
1.13B
stocks logo
ADPT.O
Adaptive Biotechnologies Corp
loss
Average P/E: 17.83
1.13B
stocks logo
VIR.O
Vir Biotechnology Inc
loss
Average P/E: 17.83
1.00B
stocks logo
AUPH.O
Aurinia Pharmaceuticals Inc
17.83
Average P/E: 17.83
105.10%
1.12B
stocks logo
NTLA.O
Intellia Therapeutics Inc
loss
Average P/E: 17.83
13.39%
995.84M
stocks logo
SNDX.O
Syndax Pharmaceuticals Inc
loss
Average P/E: 17.83
-34.49%
1.13B

GERN Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

GERN FAQs

Is GERN currently overvalued based on its P/E ratio?

According to the provided data, GERN's 5-year historical average forward P/E ratio is -8.08. GERN forward P/E ratio is -15.80, which is categorized as Undervalued.

What is the significance of the EV/EBITDA ratio for GERN?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has GERN's Price to Sales (PS) ratio evolved?

The PS ratio decreased from 96.82 to 29.70, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for GERN's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

GERN PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
-8.08
Current PE
-15.80
Overvalued PE
-1.44
Undervalued PE
-14.73

GERN EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
-3.12
Current EV
-52.21
Overvalued EV
17.21
Undervalued EV
-23.44

GERN P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
1627.43
Current PS
4.35
Overvalued PS
3263.10
Undervalued PS
-8.23

GERN Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
GERN.O
Geron Corp
loss
Average P/E: 17.83
56.29%
1.13B
stocks logo
ADPT.O
Adaptive Biotechnologies Corp
loss
Average P/E: 17.83
1.13B
stocks logo
VIR.O
Vir Biotechnology Inc
loss
Average P/E: 17.83
1.00B
stocks logo
AUPH.O
Aurinia Pharmaceuticals Inc
17.83
Average P/E: 17.83
105.10%
1.12B
stocks logo
NTLA.O
Intellia Therapeutics Inc
loss
Average P/E: 17.83
13.39%
995.84M
stocks logo
SNDX.O
Syndax Pharmaceuticals Inc
loss
Average P/E: 17.83
-34.49%
1.13B

GERN Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is GERN undervalued？Is GERN overvalued compared to its competitors？

GERN FAQs

Is GERN currently overvalued based on its P/E ratio?

According to the provided data, GERN's 5-year historical average forward P/E ratio is -8.08. GERN forward P/E ratio is -15.80, which is categorized as Undervalued.

What is the significance of the EV/EBITDA ratio for GERN?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has GERN's Price to Sales (PS) ratio evolved?

The PS ratio decreased from 96.82 to 29.70, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for GERN's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is GERN undervalued？Is GERN overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free